Claudio Guarneri

21PUBLICATIONS
110CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersDisease surveillanceAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Feb 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).

Diego Orsini, Dario Graceffa, Martina Burlando

|Jun 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.

C Bonifati, S Lembo, A G Richetta

|Jan 23, 2024
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS).

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli

|May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.

Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi

|Feb 24, 2023
Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature.

Ludovica Toffoli, Giulia Bazzacco, Claudio Conforti

Pageof 4

Frequent Collaborators

5 joint publications

Manuela Ceccarelli

4 joint publications

Emmanuele Venanzi Rullo

4 joint publications

Laura Macca

4 joint publications

Francesca Prignano